Richard Twomey

With significant experience of the medical device industry having worked for over 30 years in the field in progressively more senior roles. As Managing Director of the J&J bone tissue management group he was responsible for the development of drug-eluting devices and biologics. For the last six years he has held the position of CEO and President of Molnlycke Healthcare leaving in September 2020.